Labor LS
The Analytical Testing Powerhouse

Labor LS, one of the largest family-owned contract laboratories and a cornerstone of the Central European pharmaceutical industry, demonstrates a four-decade commitment to quality and reliability. What truly sets Labor LS apart is its impressive infrastructure. The company has a sprawling, state-of-the-art laboratory complex spanning over 15,000 square meters. This includes 7,000 square meters of dedicated lab space and 1,200 square meters of Good Manufacturing Practices (GMP) cleanrooms. These facilities enable Labor LS to handle large-scale projects and high volumes of samples, with GMP cleanrooms dedicated for tests of sterility and equipped with seven isolators, providing the necessary environment to conduct a wide array of experiments and analyses, ensuring precision and adherence to the highest industry standards.

Labor LS’s team of over 600 highly skilled professionals maintain strict adherence to GMP standards across every project. Specialising in microbiology and chemical physical analysis, the laboratory excels in batch release testing and the analysis of both end products and intermediary materials.

“Each day, we process over 1,000 routine samples, ensuring the utmost quality and safety for our clients,” says Dr. Juergen Balles, CEO.

Beyond routine analysis, Labor LS offers specialised services such as disinfectant testing and stability testing, showcasing its expertise and versatility.

The company also excels in on-site services, including environmental monitoring, sample collection and transportation to its state-of-the-art lab for analysis. Complemented by advisory support, Labor LS assists clients in establishing and maintaining robust quality systems, underlining its commitment to customer success.

Labor LS’s capabilities were prominently showcased during Germany’s pandemic readiness program, where the company played a crucial role in supporting vaccine manufacturers. Labor LS helped to qualify the new production lines and conducted extensive qualification testing, including on-site services and thorough testing of samples for the qualification steps of water systems and clean rooms.
The centralised operations in Germany allow Labor LS to maintain all expertise under one roof, creating a one-stop-shop experience for quality control (QC) analyses in GMP conditions. The company is particularly renowned for its expertise in specialised tests such as container closure integrity tests and low endotoxin recovery, which require a high level of capability not readily available elsewhere.

Expanding its reach beyond Germany, the contract laboratory now serves over 650 active clients and has earned quality approval from international authorities, including the FDA. This global recognition underscores the company’s commitment to excellence.

In daily operations, Labor LS faces the primary challenge of maintaining a sufficient workforce to meet all customer requirements. To address this, the company has established an education program modelled after the German system for training specialists. Around 45 individuals have enrolled in this program, ensuring a steady stream of qualified specialists. Processing over 1,000 samples daily, this initiative is a critical component of Labor LS’s strategy.

Anticipating a shift towards molecular biological techniques, Labor LS is exploring new ways to identify microorganisms, supported by services such as strain collection and LS-pedia. This ensures clients receive detailed and accurate microbiological analysis, essential for maintaining product safety and efficacy.

A growing area of focus for Labor LS is mycoplasma testing and the analysis required for new RNA and DNA-based vaccines. These cutting-edge fields demand sophisticated methodologies and substantial expertise. To meet these needs, Labor LS has established advanced techniques in its lab, such as the monocyte activation test, which has become the standard replacement for rabbit pyrogen tests in Europe. Its highly skilled experts navigate these specific and complex challenges, further enhancing this specialisation.

With a steadfast promise to innovation, precision and client success, Labor LS not only meets but exceeds industry standards. Its strategic foresight and ability to adapt to emerging scientific advancements ensure that it remains at the cutting edge of the pharmaceutical industry.